GREEN CROSS WellBeing Corporation Logo

GREEN CROSS WellBeing Corporation

Develops nutritional injections, health supplements, and cosmetics.

234690 | KO

Overview

Corporate Details

ISIN(s):
KR7234690006
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 여의대로 108 파크원타워2 33층, 서울특별시

Description

GREEN CROSS WellBeing Corporation is a company focused on promoting human health through personalized nutrition solutions. Its primary business areas include the development and manufacturing of prescription nutritional injections, such as its placental injection Laennec. The company also provides a range of health functional foods and supplements, including the Dr. PNT brand, which offers customized nutrient solutions based on individual health needs and expert consultation. Further product lines include cosmetics derived from proprietary cell culture technology. Research and development is a key focus, with active programs in customized probiotics tailored to different life stages, the discovery of new functional materials from natural products, and the development of novel pharmaceutical treatments for conditions such as Cancer Cachexia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-12-16 00:00
기타경영사항(자율공시) (배당기준일 관련 안내)
Korean 6.3 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.7 MB
2025-08-01 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.2 KB
2025-06-09 00:00
공정거래자율준수프로그램운영현황
Korean 5.4 KB
2025-05-29 00:00
기업설명회(IR)개최
Korean 7.0 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-30 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2025-04-09 00:00
[기재정정]타법인주식및출자증권취득결정
Korean 30.8 KB
2025-04-04 00:00
[기재정정]타법인주식및출자증권취득결정
Korean 31.0 KB
2025-03-25 00:00
정기주주총회결과
Korean 25.0 KB
2025-03-25 00:00
공정거래자율준수프로그램운영현황
Korean 15.6 KB
2025-03-17 00:00
감사보고서제출
Korean 25.0 KB
2025-03-17 00:00
사업보고서 (2024.12)
Korean 1.9 MB
2025-03-10 00:00
주주총회소집공고
Korean 189.6 KB

Automate Your Workflow. Get a real-time feed of all GREEN CROSS WellBeing Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GREEN CROSS WellBeing Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GREEN CROSS WellBeing Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.